Search This Blog

Monday, April 29, 2013

Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes | Merck Newsroom Home

Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes | Merck Newsroom Home

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.